G
GeneSystem Co Ltd
KOSDAQ:363250
GeneSystem Co Ltd
KOSDAQ:363250
Price:
4 920
KRW
Market Closed
Market Cap:
₩34.6B
Income Statement
Earnings Waterfall
GeneSystem Co Ltd
GeneSystem Co Ltd
Income Statement
GeneSystem Co Ltd
GeneSystem Co Ltd
Currency: KRW
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
446
|
464
|
102
|
89
|
89
|
88
|
88
|
91
|
95
|
106
|
117
|
124
|
134
|
137
|
138
|
144
|
136
|
134
|
133
|
127
|
|
| Revenue |
13 258
N/A
|
15 882
+20%
|
14 142
-11%
|
12 906
-9%
|
13 237
+3%
|
12 213
-8%
|
11 157
-9%
|
9 073
-19%
|
3 653
-60%
|
4 126
+13%
|
1 859
-55%
|
1 566
-16%
|
897
-43%
|
559
-38%
|
687
+23%
|
1 287
+87%
|
1 208
-6%
|
1 271
+5%
|
1 059
-17%
|
345
-67%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(4 271)
|
(3 926)
|
(4 472)
|
(4 711)
|
(4 571)
|
(4 345)
|
(4 466)
|
(4 073)
|
(2 486)
|
(3 221)
|
(2 417)
|
(2 471)
|
(2 483)
|
(2 073)
|
(2 423)
|
(2 779)
|
(3 028)
|
(3 063)
|
(2 911)
|
(2 578)
|
|
| Gross Profit |
8 987
N/A
|
11 956
+33%
|
9 670
-19%
|
8 195
-15%
|
8 666
+6%
|
7 868
-9%
|
6 691
-15%
|
5 000
-25%
|
1 167
-77%
|
905
-22%
|
(558)
N/A
|
(905)
-62%
|
(1 586)
-75%
|
(1 514)
+5%
|
(1 735)
-15%
|
(1 492)
+14%
|
(1 820)
-22%
|
(1 791)
+2%
|
(1 852)
-3%
|
(2 233)
-21%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(5 677)
|
(6 407)
|
(6 468)
|
(6 388)
|
(6 400)
|
(6 799)
|
(9 017)
|
(9 500)
|
(7 772)
|
(10 090)
|
(7 959)
|
(8 147)
|
(7 898)
|
(7 898)
|
(10 692)
|
(10 580)
|
(8 296)
|
(10 309)
|
(7 931)
|
(7 704)
|
|
| Selling, General & Administrative |
(3 557)
|
(4 009)
|
(3 759)
|
(3 821)
|
(3 544)
|
(3 732)
|
(5 107)
|
(5 388)
|
(4 448)
|
(5 676)
|
(4 433)
|
(4 505)
|
(4 188)
|
(4 128)
|
(5 350)
|
(5 145)
|
(3 961)
|
(5 126)
|
(3 898)
|
(3 889)
|
|
| Research & Development |
(1 631)
|
(1 655)
|
(1 970)
|
(1 823)
|
(2 780)
|
(3 070)
|
(3 936)
|
(4 133)
|
(3 278)
|
(4 323)
|
(3 394)
|
(3 451)
|
(3 337)
|
(3 287)
|
(4 428)
|
(4 339)
|
(3 213)
|
(3 913)
|
(2 988)
|
(2 799)
|
|
| Depreciation & Amortization |
(128)
|
(149)
|
(130)
|
(133)
|
(203)
|
(149)
|
(250)
|
(280)
|
(264)
|
(312)
|
(233)
|
(214)
|
(411)
|
(517)
|
(954)
|
(1 148)
|
(1 096)
|
(1 271)
|
(1 038)
|
(1 074)
|
|
| Other Operating Expenses |
(361)
|
(593)
|
(609)
|
(612)
|
127
|
152
|
275
|
301
|
217
|
221
|
101
|
24
|
38
|
34
|
39
|
53
|
(26)
|
1
|
(7)
|
58
|
|
| Operating Income |
3 309
N/A
|
5 550
+68%
|
3 202
-42%
|
1 807
-44%
|
2 266
+25%
|
1 068
-53%
|
(2 326)
N/A
|
(4 500)
-93%
|
(6 605)
-47%
|
(9 184)
-39%
|
(8 517)
+7%
|
(9 052)
-6%
|
(9 484)
-5%
|
(9 412)
+1%
|
(12 427)
-32%
|
(12 071)
+3%
|
(10 116)
+16%
|
(12 101)
-20%
|
(9 784)
+19%
|
(9 937)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(6 991)
|
(6 574)
|
(366)
|
168
|
952
|
682
|
916
|
384
|
(481)
|
(83)
|
(405)
|
(197)
|
1 447
|
287
|
625
|
495
|
430
|
422
|
209
|
183
|
|
| Non-Reccuring Items |
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
71
|
71
|
46
|
38
|
(53)
|
(59)
|
(12)
|
(11)
|
29
|
25
|
(72)
|
(66)
|
125
|
1 015
|
1 090
|
1 088
|
7
|
18
|
18
|
24
|
|
| Pre-Tax Income |
(3 592)
N/A
|
(953)
+73%
|
2 882
N/A
|
2 013
-30%
|
3 165
+57%
|
1 692
-47%
|
(1 423)
N/A
|
(4 127)
-190%
|
(7 060)
-71%
|
(9 242)
-31%
|
(8 994)
+3%
|
(9 314)
-4%
|
(7 913)
+15%
|
(8 110)
-2%
|
(10 713)
-32%
|
(10 488)
+2%
|
(9 679)
+8%
|
(11 661)
-20%
|
(9 556)
+18%
|
(9 730)
-2%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
1 368
|
1 368
|
(722)
|
(627)
|
387
|
386
|
724
|
629
|
(1 936)
|
(1 936)
|
(1 951)
|
0
|
(146)
|
(109)
|
(3)
|
35
|
151
|
188
|
153
|
153
|
|
| Income from Continuing Operations |
(2 224)
|
414
|
2 160
|
1 386
|
3 551
|
2 078
|
(699)
|
(3 498)
|
(8 996)
|
(11 179)
|
(10 945)
|
(11 266)
|
(8 059)
|
(8 219)
|
(10 716)
|
(10 454)
|
(9 529)
|
(11 473)
|
(9 402)
|
(9 577)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
144
|
313
|
481
|
780
|
613
|
777
|
768
|
634
|
|
| Net Income (Common) |
(2 224)
N/A
|
414
N/A
|
2 160
+421%
|
1 386
-36%
|
3 551
+156%
|
2 078
-41%
|
(699)
N/A
|
(3 498)
-401%
|
(8 996)
-157%
|
(11 179)
-24%
|
(10 945)
+2%
|
(11 266)
-3%
|
(7 915)
+30%
|
(7 907)
+0%
|
(10 234)
-29%
|
(9 674)
+5%
|
(8 915)
+8%
|
(10 696)
-20%
|
(8 634)
+19%
|
(8 943)
-4%
|
|
| EPS (Diluted) |
-326.54
N/A
|
70.6
N/A
|
357.75
+407%
|
203.55
-43%
|
554.27
+172%
|
302.06
-46%
|
-101.15
N/A
|
-505.44
-400%
|
-1 303.5
-158%
|
-1 613.08
-24%
|
-1 577.92
+2%
|
-1 618.29
-3%
|
-1 139.05
+30%
|
-1 131.95
+1%
|
-1 497.91
-32%
|
-1 422.21
+5%
|
-1 302.43
+8%
|
-1 570.58
-21%
|
-1 267.38
+19%
|
-1 313.12
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
